Popat, R., Laheij, A., Donk, N. W. V. D., Doty, R. L., Omel, J., Lipe, B., Rasche, L., Chari, A., Kato, K., Tian, S. K., Vishwamitra, D., Speier, J., Schultz, J., Bolyard, K., Gray, K., Aguilar, G., Fernandez, M., Qi, K., Sanchez, L. J. (2025). Prophylactic interventions for oral toxicities with the GPRC5D×CD3 bispecific antibody talquetamab in relapsed/refractory multiple myeloma: An update on the open-label, phase 2, randomized TALISMAN study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps7565